Philip Rising Nielsen1, Michael Eriksen Benros2, Søren Dalsgaard3. 1. National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark, and iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus University. Electronic address: prn@econ.au.dk. 2. iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus University, and Mental Health Center Copenhagen, Copenhagen University Hospital. 3. National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark, and iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus University.
Abstract
OBJECTIVE: Recent studies have suggested that autoimmune diseases and immune activation play a part in the pathogenesis of different neurodevelopmental disorders. This study investigated the association between a personal history and a family history of autoimmune disease and the risk of developing attention-deficit/hyperactivity disorder (ADHD). METHOD: A cohort was formed of all singletons born in Denmark from 1990 to 2007, resulting in a study population of 983,680 individuals followed from 1995 to 2012. Information on autoimmune diseases was obtained from the Danish National Hospital Register. Individuals with ADHD were identified through the Danish National Hospital Register and the Danish Psychiatric Central Register. RESULTS: In total, 23,645 children were diagnosed with ADHD during the study period. Autoimmune disease in the individual was associated with an increased risk of ADHD by an incidence rate ratio of 1.24 (95% CI 1.10-1.40). The primary analyses associated maternal autoimmune disease with ADHD in the offspring (incidence rate ratio 1.12, 95% CI 1.06-1.19), whereas a paternal history of autoimmune diseases was not significantly associated with ADHD in the offspring. In exploratory analyses, an increased risk of ADHD was observed for children with a family history of thyrotoxicosis, type 1 diabetes, autoimmune hepatitis, psoriasis, and ankylosing spondylitis. CONCLUSION: A personal history and a maternal history of autoimmune disease were associated with an increased risk of ADHD. The previously reported association between type 1 diabetes and ADHD was confirmed. In addition, specific parental autoimmune diseases were associated with ADHD in offspring.
OBJECTIVE: Recent studies have suggested that autoimmune diseases and immune activation play a part in the pathogenesis of different neurodevelopmental disorders. This study investigated the association between a personal history and a family history of autoimmune disease and the risk of developing attention-deficit/hyperactivity disorder (ADHD). METHOD: A cohort was formed of all singletons born in Denmark from 1990 to 2007, resulting in a study population of 983,680 individuals followed from 1995 to 2012. Information on autoimmune diseases was obtained from the Danish National Hospital Register. Individuals with ADHD were identified through the Danish National Hospital Register and the Danish Psychiatric Central Register. RESULTS: In total, 23,645 children were diagnosed with ADHD during the study period. Autoimmune disease in the individual was associated with an increased risk of ADHD by an incidence rate ratio of 1.24 (95% CI 1.10-1.40). The primary analyses associated maternal autoimmune disease with ADHD in the offspring (incidence rate ratio 1.12, 95% CI 1.06-1.19), whereas a paternal history of autoimmune diseases was not significantly associated with ADHD in the offspring. In exploratory analyses, an increased risk of ADHD was observed for children with a family history of thyrotoxicosis, type 1 diabetes, autoimmune hepatitis, psoriasis, and ankylosing spondylitis. CONCLUSION: A personal history and a maternal history of autoimmune disease were associated with an increased risk of ADHD. The previously reported association between type 1 diabetes and ADHD was confirmed. In addition, specific parental autoimmune diseases were associated with ADHD in offspring.
Authors: Daniel S Tylee; Jiayin Sun; Jonathan L Hess; Muhammad A Tahir; Esha Sharma; Rainer Malik; Bradford B Worrall; Andrew J Levine; Jeremy J Martinson; Sergey Nejentsev; Doug Speed; Annegret Fischer; Eric Mick; Brian R Walker; Andrew Crawford; Struan F A Grant; Constantin Polychronakos; Jonathan P Bradfield; Patrick M A Sleiman; Hakon Hakonarson; Eva Ellinghaus; James T Elder; Lam C Tsoi; Richard C Trembath; Jonathan N Barker; Andre Franke; Abbas Dehghan; Stephen V Faraone; Stephen J Glatt Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2018-10-16 Impact factor: 3.568
Authors: Beate Leppert; Lucy Riglin; Robyn E Wootton; Christina Dardani; Ajay Thapar; James R Staley; Kate Tilling; George Davey Smith; Anita Thapar; Evie Stergiakouli Journal: Am J Epidemiol Date: 2021-06-01 Impact factor: 4.897
Authors: Hsing-Ying Ho; Chih-Kai Wong; Szu-Yuan Wu; Ray C Hsiao; Yi-Lung Chen; Cheng-Fang Yen Journal: Int J Environ Res Public Health Date: 2021-02-01 Impact factor: 3.390
Authors: Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang Journal: Neurosci Biobehav Rev Date: 2021-02-04 Impact factor: 9.052
Authors: Miguel Garcia-Argibay; Ebba du Rietz; Yi Lu; Joanna Martin; Elis Haan; Kelli Lehto; Sarah E Bergen; Paul Lichtenstein; Henrik Larsson; Isabell Brikell Journal: Transl Psychiatry Date: 2022-04-11 Impact factor: 7.989